glp-1 weight loss drugs tirzepatide semaglutide GLP-1s for Loss: What You Need to Know GLP-1 Weight Loss Medication Program

Although these mechanisms have been exploited to facilitate weight loss, these medications have also been indicated for patients with cardiovascular or renal diseases, all of which have caused a recent drastic rise in prescribing GLP-1 RAs

Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant

Glucagon-like peptide-1 (GLP-1) is an incretin hormone mainly secreted from intestinal L cells in response to nutrient ingestion

What hypothyroid patients should know about GLP-1 and GIP weight-loss medications like Wegovy (semaglutide) and Zepbound (tirzepatide)

The clinical results so far are hard to ignore

GLP-1 receptor agonists represent a breakthrough for managing type-2 diabetes and obesity, offering metabolic benefits across multiple organ systems